Absci Corp (ABSI)

$5.36 -0.42 (-7.27%)
Market Cap 901.13M
Revenue (ttm) 2.80M
Net Income (ttm) -115.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,113.57%
Debt to Equity Ratio 0.00
Volume 4,078,600
Avg Vol 4,755,908
Day's Range N/A - N/A
Shares Out 155.91M
Stochastic %K 33%
Beta 2.36
Analysts Strong Sell
Price Target $8.15

Company Profile

Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration...

Industry: Biotechnology
Sector: Healthcare
Phone: 360 949 1041
Address:
18105 SE Mill Plain Boulevard, Vancouver, United States
flam70
flam70 May. 13 at 8:52 AM
$ABSI $AMD amd continues to hold 5.7m shared of ABSI.
0 · Reply
StocktwitsNews
StocktwitsNews May. 13 at 6:39 AM
MRVL Stock Primes For Rebound As AMD Reveals $10M Stake $MRVL $AMD $SOXX $SANM $ABSI https://stocktwits.com/news/equity/markets/mrvl-stock-primes-for-rebound-as-amd-reveals-10-m-stake/cZXLBZRRe0Q
0 · Reply
TheUnmaker
TheUnmaker May. 13 at 2:43 AM
$TNXP When do we moon back to $60 to fill the gap? $SLS $ABSI
1 · Reply
flam70
flam70 May. 12 at 9:51 PM
$ABSI jones Trading raised price target from $9-$11
0 · Reply
ABDULMOHSEN08
ABDULMOHSEN08 May. 12 at 5:13 PM
$CABA I won't repeat the same mistake I made with $ABSI when they manipulated the stock. My average price was 4.70 and my target was 6.40, and they kept manipulating the stock for several days until they forced me to sell at 5.30. But now, enough is enough. I will stay until I achieve the bigger goal.
1 · Reply
Dirk1969
Dirk1969 May. 12 at 4:12 PM
$ABCL looks like $ABSI after numbers, from red to green ✅📈
0 · Reply
MomentsOverMoney
MomentsOverMoney May. 12 at 3:49 PM
$ABSI bounceback this week still? Or will it fade out until the next bit of news? When is timeline for results on 101?
0 · Reply
TT_
TT_ May. 11 at 7:05 PM
$ABSI such strange stock price movement. Don’t understand what to do with this stock
1 · Reply
QuantInsider
QuantInsider May. 11 at 6:29 PM
$ABSI is on a roll lately, up about 8% in the last five days and another 2% today All eyes on the options flow Saw a big chunk of Jan 2028 $3 deep ITM calls traded at the ask, around $4.4M in premium No puts in sight, which means the market is leaning heavily bullish on this one Momentum is strong but without a clear news catalyst, it's smart to manage risk Going short here could be risky unless something negative pops up
0 · Reply
Wallstfan
Wallstfan May. 11 at 5:44 PM
$ABSI added more at $6.16
0 · Reply
Latest News on ABSI
Absci price target raised to $11 from $9 at JonesResearch

2026-05-13T08:40:11.000Z - 2 hours ago

Absci price target raised to $11 from $9 at JonesResearch

Absci reports Q1 EPS (19c), consensus (20c)

2026-05-07T22:23:30.000Z - 5 days ago

Absci reports Q1 EPS (19c), consensus (20c)

Absci Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 5 days ago

Absci Earnings Call Transcript: Q1 2026

Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results

May 7, 2026, 4:05 PM EDT - 5 days ago

Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

May 4, 2026, 8:11 PM EDT - 8 days ago

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026

Apr 23, 2026, 4:05 PM EDT - 19 days ago

Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026

Absci Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 16, 2026, 1:30 PM EDT - 26 days ago

Absci Transcript: 25th Annual Needham Virtual Healthcare Conference

Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference

Apr 8, 2026, 8:00 AM EDT - 4 weeks ago

Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference

Absci price target lowered to $4.20 from $4.32 at Morgan Stanley

2026-03-25T11:35:46.000Z - 6 weeks ago

Absci price target lowered to $4.20 from $4.32 at Morgan Stanley

Absci Earnings Call Transcript: Q4 2025

Mar 24, 2026, 4:30 PM EDT - 7 weeks ago

Absci Earnings Call Transcript: Q4 2025

Absci reports Q4 EPS (20c), consensus (17c)

2026-03-24T20:13:40.000Z - 7 weeks ago

Absci reports Q4 EPS (20c), consensus (17c)

Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results

Mar 24, 2026, 4:05 PM EDT - 7 weeks ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results

AbSci Corp options imply 13.4% move in share price post-earnings

2026-03-24T18:05:57.000Z - 7 weeks ago

AbSci Corp options imply 13.4% move in share price post-earnings

Options Volatility and Implied Earnings Moves Today, March 24, 2026

2026-03-24T12:05:19.000Z - 7 weeks ago

Options Volatility and Implied Earnings Moves Today, March 24, 2026

ACHV AIR BRZE DPRO EVTL GME KBH

Absci Transcript: Leerink Global Healthcare Conference 2026

Mar 9, 2026, 10:00 AM EDT - 2 months ago

Absci Transcript: Leerink Global Healthcare Conference 2026

Absci appoints Ransi Somaratne as CMO

2026-03-03T13:10:19.000Z - 2 months ago

Absci appoints Ransi Somaratne as CMO

VRTX

Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer

Mar 3, 2026, 8:00 AM EST - 2 months ago

Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer

Absci Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 9:10 AM EST - 2 months ago

Absci Transcript: TD Cowen 46th Annual Health Care Conference

Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026

Feb 24, 2026, 8:00 AM EST - 2 months ago

Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026

AMD discloses positions in Absci, Sanmina

2026-02-17T15:15:21.000Z - 3 months ago

AMD discloses positions in Absci, Sanmina

AMD SANM

Absci to Participate in Upcoming Investor Conferences

Feb 17, 2026, 8:00 AM EST - 3 months ago

Absci to Participate in Upcoming Investor Conferences

Absci Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 6:45 PM EST - 4 months ago

Absci Transcript: 44th Annual J.P. Morgan Healthcare Conference

Absci downgraded to Equal Weight from Overweight at Morgan Stanley

2026-01-08T11:15:21.000Z - 4 months ago

Absci downgraded to Equal Weight from Overweight at Morgan Stanley

Absci price target raised to $8 from $7 at H.C. Wainwright

2025-12-17T17:40:17.000Z - 5 months ago

Absci price target raised to $8 from $7 at H.C. Wainwright

Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 16, 2025, 8:00 AM EST - 5 months ago

Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Absci Transcript: Status Update

Dec 11, 2025, 10:00 AM EST - 5 months ago

Absci Transcript: Status Update

Absci’s ABS-201 shows efficacy in hair regeneration

2025-12-11T13:11:11.000Z - 5 months ago

Absci’s ABS-201 shows efficacy in hair regeneration

Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization

Dec 11, 2025, 8:00 AM EST - 5 months ago

Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization

Absci, former U.S. soccer player Donovan announce partnership

2025-12-10T13:05:10.000Z - 5 months ago

Absci, former U.S. soccer player Donovan announce partnership

Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research

Dec 10, 2025, 8:00 AM EST - 5 months ago

Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research

Absci announces first participants dosed in Phase 1/2a HEADLINE trial

2025-12-04T13:05:52.000Z - 5 months ago

Absci announces first participants dosed in Phase 1/2a HEADLINE trial

Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia

Dec 4, 2025, 8:00 AM EST - 5 months ago

Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia

Absci Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 4:30 AM EST - 6 months ago

Absci Transcript: Jefferies London Healthcare Conference 2025

Absci reports Q3 EPS (20c), consensus (21c)

2025-11-12T21:31:13.000Z - 6 months ago

Absci reports Q3 EPS (20c), consensus (21c)

Absci expects cash to fund operations into the first half of 2028

2025-11-12T21:30:23.000Z - 6 months ago

Absci expects cash to fund operations into the first half of 2028

Absci Earnings Call Transcript: Q3 2025

Nov 12, 2025, 4:30 PM EST - 6 months ago

Absci Earnings Call Transcript: Q3 2025

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

Nov 12, 2025, 4:05 PM EST - 6 months ago

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

AbSci Corp options imply 13.2% move in share price post-earnings

2025-11-12T20:45:28.000Z - 6 months ago

AbSci Corp options imply 13.2% move in share price post-earnings

Absci Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Nov 10, 2025, 10:00 AM EST - 6 months ago

Absci Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

Oct 29, 2025, 4:05 PM EDT - 6 months ago

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Oct 15, 2025, 8:00 AM EDT - 7 months ago

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Sep 11, 2025, 8:00 AM EDT - 8 months ago

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Absci Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 9, 2025, 9:30 AM EDT - 8 months ago

Absci Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Absci Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 8, 2025, 3:20 PM EDT - 8 months ago

Absci Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Aug 25, 2025, 4:05 PM EDT - 9 months ago

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Absci Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 9 months ago

Absci Earnings Call Transcript: Q2 2025

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Aug 12, 2025, 4:05 PM EDT - 9 months ago

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Aug 7, 2025, 2:00 AM EDT - 9 months ago

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Jul 30, 2025, 4:05 PM EDT - 10 months ago

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Absci Announces Pricing of Public Offering of Common Stock

Jul 24, 2025, 8:45 PM EDT - 10 months ago

Absci Announces Pricing of Public Offering of Common Stock

Absci Announces Proposed Public Offering of Common Stock

Jul 24, 2025, 4:54 PM EDT - 10 months ago

Absci Announces Proposed Public Offering of Common Stock

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

Jul 7, 2025, 8:00 AM EDT - 11 months ago

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

Absci Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 9, 2025, 8:40 AM EDT - 1 year ago

Absci Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Absci Transcript: Jefferies Global Healthcare Conference 2025

Jun 5, 2025, 2:00 PM EDT - 1 year ago

Absci Transcript: Jefferies Global Healthcare Conference 2025

Absci Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Absci Earnings Call Transcript: Q1 2025

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

May 13, 2025, 4:05 PM EDT - 1 year ago

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

May 13, 2025, 4:01 PM EDT - 1 year ago

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Apr 14, 2025, 4:05 PM EDT - 1 year ago

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Absci Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 8, 2025, 11:45 AM EDT - 1 year ago

Absci Transcript: 24th Annual Needham Virtual Healthcare Conference

Absci Transcript: H.C. Wainwright 2nd Annual Artificial Intelligence Based Drug Discovery & Development Conference

Apr 2, 2025, 10:30 AM EDT - 1 year ago

Absci Transcript: H.C. Wainwright 2nd Annual Artificial Intelligence Based Drug Discovery & Development Conference

Absci Transcript: KeyBanc Annual Health Care Forum 2025

Mar 19, 2025, 9:00 AM EDT - 1 year ago

Absci Transcript: KeyBanc Annual Health Care Forum 2025

Absci Earnings Call Transcript: Q4 2024

Mar 18, 2025, 4:30 PM EDT - 1 year ago

Absci Earnings Call Transcript: Q4 2024

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 18, 2025, 4:05 PM EDT - 1 year ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Mar 4, 2025, 4:05 PM EST - 1 year ago

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Mar 4, 2025, 8:00 AM EST - 1 year ago

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Absci Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 3, 2025, 3:10 PM EST - 1 year ago

Absci Transcript: TD Cowen 45th Annual Healthcare Conference

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 18, 2025, 8:00 AM EST - 1 year ago

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Absci Transcript: Guggenheim SMID Cap Biotech Conference

Feb 5, 2025, 3:00 PM EST - 1 year ago

Absci Transcript: Guggenheim SMID Cap Biotech Conference

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Jan 22, 2025, 8:00 AM EST - 1 year ago

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Absci Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

Absci Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Jan 10, 2025, 7:30 AM EST - 1 year ago

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Jan 8, 2025, 7:00 AM EST - 1 year ago

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Jan 6, 2025, 8:00 AM EST - 1 year ago

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Absci Transcript: R&D Day 2024

Dec 12, 2024, 9:00 AM EST - 1 year ago

Absci Transcript: R&D Day 2024

Absci Transcript: Stifel 2024 Healthcare Conference

Nov 18, 2024, 1:50 PM EST - 1 year ago

Absci Transcript: Stifel 2024 Healthcare Conference

Absci Transcript: UBS Global Healthcare Conference

Nov 13, 2024, 10:15 AM EST - 1 year ago

Absci Transcript: UBS Global Healthcare Conference

Absci Earnings Call Transcript: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Absci Earnings Call Transcript: Q3 2024

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Nov 12, 2024, 7:30 AM EST - 1 year ago

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Absci Transcript: Guggenheim Inaugural Global Healthcare Conference

Nov 11, 2024, 10:00 AM EST - 1 year ago

Absci Transcript: Guggenheim Inaugural Global Healthcare Conference

Absci to Host R&D Day on December 12, 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Absci to Host R&D Day on December 12, 2024

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Absci Transcript: H.C. Wainwright 26th Annual Global Investment Conference

Sep 10, 2024, 11:00 AM EDT - 1 year ago

Absci Transcript: H.C. Wainwright 26th Annual Global Investment Conference

Absci Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Sep 5, 2024, 5:35 PM EDT - 1 year ago

Absci Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Absci Earnings Call Transcript: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 1 year ago

Absci Earnings Call Transcript: Q2 2024

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Aug 14, 2024, 4:01 PM EDT - 1 year ago

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

Aug 12, 2024, 8:00 AM EDT - 1 year ago

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

Jul 10, 2024, 8:00 AM EDT - 1 year ago

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

Absci Transcript: Goldman Sachs 45th Annual Global Healthcare Conference

Jun 10, 2024, 2:00 PM EDT - 2 years ago

Absci Transcript: Goldman Sachs 45th Annual Global Healthcare Conference

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

May 28, 2024, 8:00 AM EDT - 2 years ago

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Absci Earnings Call Transcript: Q1 2024

May 14, 2024, 8:00 AM EDT - 2 years ago

Absci Earnings Call Transcript: Q1 2024

Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results

May 14, 2024, 7:30 AM EDT - 2 years ago

Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results

Absci Transcript: 23rd Annual Needham Virtual Healthcare Conference

Apr 8, 2024, 3:00 PM EDT - 2 years ago

Absci Transcript: 23rd Annual Needham Virtual Healthcare Conference

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results

Mar 21, 2024, 7:30 AM EDT - 2 years ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results

Absci Transcript: KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Mar 19, 2024, 10:30 AM EDT - 2 years ago

Absci Transcript: KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Absci Transcript: H.C. Wainwright 1st Annual AI Based Drug Discovery & Development Conference (Virtual)

Mar 7, 2024, 10:30 AM EST - 2 years ago

Absci Transcript: H.C. Wainwright 1st Annual AI Based Drug Discovery & Development Conference (Virtual)

Absci Transcript: KeyBanc’s Emerging Technology Summit

Mar 6, 2024, 12:00 PM EST - 2 years ago

Absci Transcript: KeyBanc’s Emerging Technology Summit

Absci Transcript: TD Cowen 44th Annual Health Care Conference

Mar 4, 2024, 2:10 PM EST - 2 years ago

Absci Transcript: TD Cowen 44th Annual Health Care Conference

Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Mar 1, 2024, 4:01 PM EST - 2 years ago

Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI

Feb 21, 2024, 7:30 AM EST - 2 years ago

Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI

Absci Transcript: 26th Annual Needham Growth Virtual Conference

Jan 19, 2024, 9:30 AM EST - 2 years ago

Absci Transcript: 26th Annual Needham Growth Virtual Conference

Absci Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Jan 11, 2024, 1:30 PM EST - 2 years ago

Absci Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Absci Appoints Professor Sir Mene Pangalos to its Board of Directors

Jan 10, 2024, 7:30 AM EST - 2 years ago

Absci Appoints Professor Sir Mene Pangalos to its Board of Directors

Absci to Participate in the 26th Annual Needham Growth Conference

Jan 3, 2024, 8:00 AM EST - 2 years ago

Absci to Participate in the 26th Annual Needham Growth Conference

Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Dec 28, 2023, 8:00 AM EST - 2 years ago

Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline

Dec 20, 2023, 7:30 AM EST - 2 years ago

Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline

Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate

Dec 4, 2023, 7:30 AM EST - 2 years ago

Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate

flam70
flam70 May. 13 at 8:52 AM
$ABSI $AMD amd continues to hold 5.7m shared of ABSI.
0 · Reply
StocktwitsNews
StocktwitsNews May. 13 at 6:39 AM
MRVL Stock Primes For Rebound As AMD Reveals $10M Stake $MRVL $AMD $SOXX $SANM $ABSI https://stocktwits.com/news/equity/markets/mrvl-stock-primes-for-rebound-as-amd-reveals-10-m-stake/cZXLBZRRe0Q
0 · Reply
TheUnmaker
TheUnmaker May. 13 at 2:43 AM
$TNXP When do we moon back to $60 to fill the gap? $SLS $ABSI
1 · Reply
flam70
flam70 May. 12 at 9:51 PM
$ABSI jones Trading raised price target from $9-$11
0 · Reply
ABDULMOHSEN08
ABDULMOHSEN08 May. 12 at 5:13 PM
$CABA I won't repeat the same mistake I made with $ABSI when they manipulated the stock. My average price was 4.70 and my target was 6.40, and they kept manipulating the stock for several days until they forced me to sell at 5.30. But now, enough is enough. I will stay until I achieve the bigger goal.
1 · Reply
Dirk1969
Dirk1969 May. 12 at 4:12 PM
$ABCL looks like $ABSI after numbers, from red to green ✅📈
0 · Reply
MomentsOverMoney
MomentsOverMoney May. 12 at 3:49 PM
$ABSI bounceback this week still? Or will it fade out until the next bit of news? When is timeline for results on 101?
0 · Reply
TT_
TT_ May. 11 at 7:05 PM
$ABSI such strange stock price movement. Don’t understand what to do with this stock
1 · Reply
QuantInsider
QuantInsider May. 11 at 6:29 PM
$ABSI is on a roll lately, up about 8% in the last five days and another 2% today All eyes on the options flow Saw a big chunk of Jan 2028 $3 deep ITM calls traded at the ask, around $4.4M in premium No puts in sight, which means the market is leaning heavily bullish on this one Momentum is strong but without a clear news catalyst, it's smart to manage risk Going short here could be risky unless something negative pops up
0 · Reply
Wallstfan
Wallstfan May. 11 at 5:44 PM
$ABSI added more at $6.16
0 · Reply
MAs_Crxss
MAs_Crxss May. 11 at 2:12 PM
$ABSI I’m sitting on over 100%.. too bad I’m never selling
2 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 2:02 PM
$ABSI Current Stock Price: $6.35 Contracts to trade: $6.0 ABSI May 15 2026 Call Entry: $0.14 Exit: $0.19 ROI: 41% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
MomentsOverMoney
MomentsOverMoney May. 11 at 1:59 PM
$ABSI what is going on?
1 · Reply
Kennynails
Kennynails May. 11 at 1:59 PM
$ABSI Clear skies if we can close here 👀👀👀
0 · Reply
7m3835d3
7m3835d3 May. 11 at 1:35 PM
$ABSI wow, great to see that the market is excited about the recent call and Absci’s outlook!
0 · Reply
flam70
flam70 May. 11 at 12:10 PM
$ABSI we have now lost the third head of AI since ive been involved (josh meir, (started Chai Discovery) amaro taylor Weiner (?)and now Amir S. (Went to Anthropic) i appreciate anyones tjoughts, is there just too much opportunity in the space and absci doesnt offer enough $? Any intelligent thoughts appreciated.
1 · Reply
flam70
flam70 May. 11 at 12:07 PM
$ABSI https://www.linkedin.com/posts/amirshane_im-excited-to-share-updates-to-our-origin-share-7458606552451715072-O-vn?utm_source=social_share_send&utm_medium=android_app&rcm=ACoAAANo6pQBCIF-Wc4f2krmT0uqAEWRN9CcBfE&utm_campaign=whatsapp
0 · Reply
flam70
flam70 May. 11 at 10:33 AM
$ABSI ARKG bought 26k more shares on Friday. Fyi
1 · Reply
JennyRowes
JennyRowes May. 9 at 6:13 PM
$ABSI call summary: - absi201 is the key to value creation - cash burn reasonable, revenue nominal - killed both cancer programs - evasive on difference between absi201 and Absi202, and sounds like it is some pricing strategy thing - partnership promises broken and have morphed into selling early assets (we shall see) - agentic AI was emphasized as path to ”efficiencies” which could mean lower spend on G&A - emphasis on platform solving difficult targets so maybe we get some evidence soon
2 · Reply
Makingmillions192
Makingmillions192 May. 8 at 10:20 PM
$ABSI x $LEXX : AI Discovery meets Elite Delivery! 🚀 Absci is redefining medicine with generative AI for candidates like ABS-101 and ABS-201. The hurdle for AI-designed drugs is delivery—enter Lexaria’s DehydraTECH (DHT). Imagine AI-designed molecules delivered via highly bioavailable oral tablets. $LEXX just hit commercial-scale tablet manufacturing. With Human Study #7 dosing starting mid-June 2026, we are at the ultimate validation point for oral GLP-1s and clinical-stage pharma candidates. AI creates the "bullet," but DHT is the "missile" ensuring it hits the target. Don’t watch the ticker—watch the science. The Tech-Bio future is oral. 🎯💊
0 · Reply
Blockwave1
Blockwave1 May. 8 at 10:09 PM
Even at dinner 😁🚀 $ABSI still printing profits. This is what patience and strong setups look like 📈
0 · Reply
Chicharrones
Chicharrones May. 8 at 9:33 PM
$ABSI thought this was crashing? that’s a good signal.
0 · Reply